Prevalence of high-risk human papillomavirus types (HPV-16, HPV-18) and their physical status in primary laryngeal squamous cell carcinoma

Neoplasma

Volumn 57, Issue 6, 2010, Pages 595-600

  Liu, B ^a   Lu, Z ^a   Wang, P ^a   Basang, Z ^a   Rao, X ^b  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b PEKING UNIVERSITY SHOUGANG HOSPITAL   (China)

Author keywords

Human papillomavirus(HPV); Laryngeal squamous cell carcinoma (LSCC)

Indexed keywords

VIRUS DNA; CAPSID PROTEIN; DNA BINDING PROTEIN; E7 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; PROTEIN E7;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPISOME; FEMALE; GENOTYPE; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INFECTION RISK; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS DNA CELL DNA INTERACTION; VIRUS EXAMINATION; VIRUS GENE; ADULT; AGED; GENETICS; ISOLATION AND PURIFICATION; LARYNX TUMOR; MIDDLE AGED; POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VIROLOGY;

ADULT; AGED; CAPSID PROTEINS; CARCINOMA, SQUAMOUS CELL; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; POLYMERASE CHAIN REACTION;

EID: 84863234718     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_06_594     Document Type: Article

References (34)

1. GILLISON ML, D'SOUZA G, WESTRA W, SUGAR E, XIAO W et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-20.
2. KREIMER AR, CLIERFFORD GM, BOYLE P, FRANCESCHI S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005; 14: 467-475. doi:10.1158/1055-9965.EPI-04-0551
3. Zur Hausen H. Papillomavirus infections-a major cause of human cancers. BBA 1996; 1288:55-78.
4. HERRINGTON CS, ANGERSON SM, BAUER HM, TRONCONE B, DE ANGELIS ML et al. Comparative analysis of human papillomavirus detection by PCR and non-isotopic in situ hybridization. J Clin Pathol 1995; 48: 415-419. doi:10.1136/jcp.48.5.415
5. LI T, LU Z, CHEN K, GUO M, XING H et al. Human papillomavirus type 16 is an important infectious factor in the high incidence of esophageal cancer in Anyang area of China. Carcinogenesis 2001; 22, 929-934. doi:10.1093/carcin/22.6.929
6. CULLEN AP, REID R, CAMPION M, LÖRINCZ AT. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol 1991; 65: 606-612.
7. HUANG L-W, CHAO S-L, LEEB-H. Integration of human papillomavirus type-16 and type-18 is a very early event in cervical carcinogenesis. Journal of Clinical Pathology 2008; 61: 627-631. doi:10.1136/jcp.2007.052027
8. CHOO KB, PAN CC, HAN SH. Integration of human papillomavirus type 16 into cellular DNA of cervical carcinoma: preferential deletion of the E2 gene and invariable retention of the long control region and the E6/E7 open reading frames. Virology 1987; 161:259-261. doi:10.1016/0042-6822(87)90195-4
9. SAUNIER M, MONNIER-BENOIT S, MAUNY F, DALSTEIN V, BRIOLAT J et al. Analysis of Human Papillomavirus Type 16 (HPV16) DNA Load and Physical State for Identification of HPV16-Infected Women with High-Grade Lesions or Cervical Carcinoma. J Clin Microbiol 2008; 46: 3678-3685. doi:10.1128/JCM.01212-08
10. Briolat J, V DALSTEIN M, SAUNIER K, JOSEPH S, CAUDROY J et al. HPV prevalence, viral load and physical state of HPV-16 in cervical smears of patients with different grades of CIN Int J Cancer 2007; 121:2198-2204. doi:10.1002/ijc.22959
11. LI T, LU Z, GUO M, WU Q, CHEN K et al. p53 Codon 72 Polymorphism (C/G) and the Risk of Human Papillomavirus-Associated Carcinomas in China. Cancer 2002;95: 2571-2576. doi:10.1002/cncr.11008
12. DE RODA HUSMAN AM, WALBOOMERS JM, VAN DEN BRULE AJ, MEIJER CJ, SNIJDERS PJ. The use of general primers GP5 and GP6 elongated at their 3 ends with adjacents highly conserved sequences improves human papillomavirus detection by polymerase chain reaction. J Gen Virol 1995; 76:1057-1062.
13. EVANS MF, ADAMSON CS, SIMMONS-ARNOLD L, COOPER K. Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus. BMC Clinical Pathology 2005; 5:10 doi:10.1186/1472-6890-5-10
14. DE VILLERS EM, WHITLEY C, GUNST K. Identification of New Papillomavirus Types. In Methods in Molecular Medicine, Vol. 119: Human Papillomaviruses: Methods and Protocols(Davy C. and Doorbar J.)Humana Press Inc., Totowa, NJ,2005: 1-13
15. SEEDORF K, KRAMMER G, DUERST M, SUHAI S, ROWEKAMP WG. Human papillomavirus type 16 DNA sequence. Virology 1985;145: 181-185. doi:10.1016/0042-6822(85)90214-4
16. RINGSTRÖM E, PETERS E, HASEGAWA M, POSNER M, LIU M et al. Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 2002;8:3187-92.
17. GILLISON ML, KOCH WM, CAPONE RB, SPAFFORD M, WESTRA WH et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92:709-20. doi:10.1093/jnci/92.9.709
18. HERRERO R, CASTELLSAGUE X, PAWLITA M, LISSOWS-KA J, KEE F et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95: 1772-83.
19. VENUTI A, MANNI V, MORELLO R, DE MARCO F, MARZETTI F et al. Physical state and expression of human papillomavirus in laryngeal carcinoma and surrounding normal mucosa. J Med Virol 2000; 60:396-402. doi:10.1002/(SICI)1096-9071(200004)60:4<396::AIDJMV6> 3.0.CO;2-V
20. JUNG AC, BRIOLAT J, MILLON R, DE REYNIES A, RICKMAN D et al. Biological and clinical relevance of transcriptionnally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 2010; 126:1882-1894.
21. BADARACCO G, VENUTI A, MORELLO R, MULLER A, MARCANTE ML. Human papillomavirus in head and neck carcinomas: prevalence, physical status and relationship with clinical/pathological parameters. Anticancer Res 2000; 20(2B):1301-5.
22. ROUSSEAU MC, ABRAHAMOWICZ M, VILLA L, COSTA MC, ROHAN TE et al. Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiol Biomarkers Prev 2003; 12: 1029-1037.
23. SCHELLEKENS M, DIJKMAN A, AZIZ M, SIREGAR B, CORNAIN S et al. Prevalence of single and multiple HPV types in cervical carcinomas in Jakarta, Indonesia. Gynecol Oncol 2003;93: 49-53. doi:10.1016/j.ygyno.2003.12.015
24. BADARACCO G, VENUTI A, SEDATI A, MARCANTE ML. HPV16 and HPV18 in genital tumors: significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 2002; 67:574-82. doi:10.1002/jmv.10141
25. HUDELIST G, MANAVI M, PISCHINGER KI, WATKINS-RIL T, SEDELINGER CF et al. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 2004; 92:873-80. doi:10.1016/j.ygyno.2003.11.035
26. JEON S, LAMBERT PF. Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 1995; 92:1654-8. doi:10.1073/pnas.92.5.1654
27. PARK TW, FUJIWARA H, WRIGHT TC. Molecular biology of cervical cancer and its precursors. Cancer 1995; 76:1902-13. doi:10.1002/1097-0142(19951115)76:10+<1902::AIDCNCR2820761306> 3.0.CO;2-0
28. FAKHRY C, WESTRA WH, SIGUI L et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100 261-269. doi:10.1093/jnci/djn011
29. LI W, THOMPSON CH, O'BRIEN CJ, MCNEIL EB, SCOLYER RA et al. Human papillomavirus positivity predicts favorable outcome for squamous carcinoma of the tonsil. Int J Cancer 2003; 106:553-8. doi:10.1002/ijc.11261
30. RITCHIE JM, SMITH EM, SUMMERSGILL KF, HOFFMAN HT, WANG D et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 2003; 104:336-44. doi:10.1002/ijc.10960
31. LINDEL K, BEER KT, LAISUE J, GREINER RH, AEBERSOLD DM. Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer.2001; 92:805-13. doi:10.1002/1097-0142(20010815)92:4<805::AID CNCR1386>3.0.CO;2-9
32. KHAN MJ, CASTLE PE, LORINCZ AT, WACHOLDER S, SHERMANM et al. The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical Practice. J Natl Cancer Inst 2005; 97: 1072-1079. doi:10.1093/jnci/dji187
33. HERRERO R, CASTELLSAGUE X, PAWLITA M. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 2003; 95:1772-1783.
34. ARIAS-PULIDO H, PEYTON CL, JOSTE NE, VARGAS H, WHEELER CM. Human Papillomavirus Type 16 Integration in Cervical Carcinoma In Situ and in Invasive Cervical Cancer J Clin Microbiol 2006; 44: 1755-1762.